...
search icon
slxn-img

Biomotion Sciences Ordinary Shares Share Price

SLXN
NAQ
$1.88
-$0.08
(-4.08%)
1D
Industry: Biotechnology Sector: Health Care

Biomotion Sciences Ordinary Shares Analyst Forecast

Biomotion Sciences Ordinary Shares Share Price Chart

Biomotion Sciences Ordinary Shares Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.53M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.0056
Volume info-icon
This is the total number of shares traded during the most recent trading day.
32.68K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.04
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.42 L
$22.36 H
$1.88

About Biomotion Sciences Ordinary Shares, Common Stock

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel. more

Industry: BiotechnologySector: Health Care

Biomotion Sciences Ordinary Shares Stock Returns

Time FrameSLXNSectorS&P500
1-Week Return13.12%-1.58%-0.31%
1-Month Return13.94%-0.69%-1.99%
3-Month Return-37.75%1.39%-1.32%
6-Month Return-58.08%12.33%4.02%
1-Year Return-90.85%4.46%21.01%
3-Year Return-98.77%24.25%75.88%
5-Year Return-98.75%35.72%74.21%

Biomotion Sciences Ordinary Shares Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue----25.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit----(25.00K)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-2500000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses195.86K943.93K3.86M4.68M12.57M[{"date":"2020-12-31","value":1.56,"profit":true},{"date":"2021-12-31","value":7.51,"profit":true},{"date":"2022-12-31","value":30.71,"profit":true},{"date":"2023-12-31","value":37.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(195.86K)(943.93K)(3.86M)(4.68M)(12.57M)[{"date":"2020-12-31","value":-19586000,"profit":false},{"date":"2021-12-31","value":-94393300,"profit":false},{"date":"2022-12-31","value":-386000000,"profit":false},{"date":"2023-12-31","value":-468100000,"profit":false},{"date":"2024-12-31","value":-1257100000,"profit":false}]
Total Non-Operating Income/Expense--425.00K(251.00K)(8.78M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-59.06,"profit":false},{"date":"2024-12-31","value":-2065.65,"profit":false}]
Pre-Tax Income(195.86K)(755.22K)(3.46M)(5.08M)(16.51M)[{"date":"2020-12-31","value":-19586000,"profit":false},{"date":"2021-12-31","value":-75521800,"profit":false},{"date":"2022-12-31","value":-346400000,"profit":false},{"date":"2023-12-31","value":-507600000,"profit":false},{"date":"2024-12-31","value":-1650900000,"profit":false}]
Income Taxes--24.00K32.00K10.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":75,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":31.25,"profit":true}]
Income After Taxes--(3.49M)(5.11M)(16.52M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-348800000,"profit":false},{"date":"2023-12-31","value":-510800000,"profit":false},{"date":"2024-12-31","value":-1651900000,"profit":false}]
Income From Continuous Operations--(3.49M)(5.11M)(16.52M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-348800000,"profit":false},{"date":"2023-12-31","value":-510800000,"profit":false},{"date":"2024-12-31","value":-1651900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(195.86K)(755.22K)(3.21M)(4.94M)(16.44M)[{"date":"2020-12-31","value":-19586000,"profit":false},{"date":"2021-12-31","value":-75521800,"profit":false},{"date":"2022-12-31","value":-321500000,"profit":false},{"date":"2023-12-31","value":-494200000,"profit":false},{"date":"2024-12-31","value":-1644300000,"profit":false}]
EPS (Diluted)-(0.06)0.42(0.41)(585.53)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.35,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-98.01,"profit":false},{"date":"2024-12-31","value":-140079.02,"profit":false}]

Biomotion Sciences Ordinary Shares Ratios

Biomotion Sciences Ordinary Shares Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

SLXN
Cash Ratio 3.32
Current Ratio 3.97

Biomotion Sciences Ordinary Shares Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SLXN
ROA (LTM) -77.60%
ROE (LTM) -771.23%

Biomotion Sciences Ordinary Shares Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SLXN
Debt Ratio Lower is generally better. Negative is bad. 0.40
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.60

Biomotion Sciences Ordinary Shares Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SLXN
Trailing PE 0.01
Forward PE NM
P/S (TTM) 0.00
P/B 0.94
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Biomotion Sciences Ordinary Shares share price today?

Biomotion Sciences Ordinary Shares (SLXN) share price today is $1.88

Can Indians buy Biomotion Sciences Ordinary Shares shares?

Yes, Indians can buy shares of Biomotion Sciences Ordinary Shares (SLXN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SLXN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biomotion Sciences Ordinary Shares be purchased?

Yes, you can purchase fractional shares of Biomotion Sciences Ordinary Shares (SLXN) via the Vested app. You can start investing in Biomotion Sciences Ordinary Shares (SLXN) with a minimum investment of $1.

How to invest in Biomotion Sciences Ordinary Shares shares from India?

You can invest in shares of Biomotion Sciences Ordinary Shares (SLXN) via Vested in three simple steps:

  • Click on Sign Up or Invest in SLXN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Biomotion Sciences Ordinary Shares shares
What is Biomotion Sciences Ordinary Shares 52-week high and low stock price?

The 52-week high price of Biomotion Sciences Ordinary Shares (SLXN) is $22.36. The 52-week low price of Biomotion Sciences Ordinary Shares (SLXN) is $1.42.

What is Biomotion Sciences Ordinary Shares price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biomotion Sciences Ordinary Shares (SLXN) is 0.0056

What is Biomotion Sciences Ordinary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biomotion Sciences Ordinary Shares (SLXN) is 0.94

What is Biomotion Sciences Ordinary Shares dividend yield?

The dividend yield of Biomotion Sciences Ordinary Shares (SLXN) is 0.00%

What is the Market Cap of Biomotion Sciences Ordinary Shares?

The market capitalization of Biomotion Sciences Ordinary Shares (SLXN) is $6.53M

What is Biomotion Sciences Ordinary Shares's stock symbol?

The stock symbol (or ticker) of Biomotion Sciences Ordinary Shares is SLXN

How Can Investors Use Biomotion Sciences Ordinary Shares Share Price Data for Long-Term Investment Decisions?

Consider the share price of Biomotion Sciences Ordinary Shares as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Biomotion Sciences Ordinary Shares has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Biomotion Sciences Ordinary Shares shares for Indian investors?

When investing in Biomotion Sciences Ordinary Shares shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Biomotion Sciences Ordinary Shares stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Biomotion Sciences Ordinary Shares share price with other stocks in the same sector?

Rather than merely checking the share price of Biomotion Sciences Ordinary Shares and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Biomotion Sciences Ordinary Shares stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top